FDA clears US trials of Green Valley’s Alzheimer’s drug

FDA clears US trials of Green Valley’s Alzheimer’s drug

Submitted by admin on April 27, 2020 - 9:31am
Source: 
Pharmaforum
News Tags: 
Green Valley Pharmaceuticals
China
clinical trials
FDA
Alzheimer's disease
Oligomannate
Headline: 
FDA clears US trials of Green Valley’s Alzheimer’s drug
snippet: 

China’s Shanghai Green Valley Pharmaceuticals has clearance to begin a late stage clinical trial to support a US filing of its potential Alzheimer’s drug.

Do Not Allow Advertisers to Use My Personal information